
Standard Chem & Pharm Co Ltd
TWSE:1720

Net Margin
Standard Chem & Pharm Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
TW |
![]() |
Standard Chem & Pharm Co Ltd
TWSE:1720
|
11.3B TWD |
13%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
793.6B USD |
24%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
393.8B USD |
16%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.3T DKK |
35%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
246.5B CHF |
20%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
235.8B USD |
27%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
180B GBP |
13%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
200.9B CHF |
23%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
166.1B USD |
-126%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
148.9B USD |
13%
|
Standard Chem & Pharm Co Ltd
Glance View
Standard Chemical & Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese and western medicine, medicine raw materials, and health food. The company is headquartered in Tainan, Tainan. The Company’s products cover drugs for circulation systems, digest systems, respiratory systems, nervous systems and other diseases. Through its subsidiaries, the Company is also engaged in the sales of medical equipment, animal medicine, milk powder, cosmetics and others. The firm distributes its products both in domestic markets and overseas markets.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Standard Chem & Pharm Co Ltd's most recent financial statements, the company has Net Margin of 12.6%.